Categories
Uncategorized

Coronavirus: New COVID variants may evade current treatments—or render them entirely ineffective, experts say | Fortune

One rising variant, BA.2.75.2, is particularly concerning for its potential to thwart the last monoclonal antibody left in the COVID arsenal: Bebtelovimab.
— Read on fortune.com/well/2022/09/22/new-covid-variants-subvariants-may-evade-treatments-eliminate-bebtelovimab-paxlovid-omicron-monoclonal-antibodies-vaccine-immune-evasion/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s